Delivery Order SPE2DB22D3401-SPE2DB24FT2EB
Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $4.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML medical supplies to the Defense Logistics Agency (DLA). The $2,340.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,751.90 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 5, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML vaccine to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $1,400.76 firm fixed-price delivery order contract has a completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $1,291.12 firm fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not utilize a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,342.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 3, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.62 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $2,356.10 to Amerisourcebergen Drug Corporation's Corporate Office division. This Firm Fixed Price contract is for the supply of 4564559769 ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award, valued at $2,613.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to be completed by June 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,655.75 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a completion date of June 11, 2024. Amerisourcebergen, as a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,378.20 firm fixed-price delivery order contract is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...